Current treatment options for insomnia

Drugs of Today

Volumn 48, Issue 6, 2012, Pages 415-423

  Buford, U J ^a   Nemeroff, C B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Benzodiazepines; Insomnia; Sedative hypnotics; Sleep disorders

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; CLONIDINE; DIPHENHYDRAMINE; DOXEPIN; DOXYLAMINE; ESTAZOLAM; ESZOPICLONE; FLURAZEPAM; INTERMEZZO; LORAZEPAM; NORTRIPTYLINE; QUAZEPAM; RAMELTEON; TEMAZEPAM; TRIAZOLAM; UNCLASSIFIED DRUG; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE; ZOPICLONE;

ACUPRESSURE; ACUPUNCTURE; BLOOD BRAIN BARRIER; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COGNITIVE THERAPY; DAYTIME SOMNOLENCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; GABAERGIC TRANSMISSION; HEADACHE; HUMAN; INSOMNIA; NONREM SLEEP; PARASOMNIA; PSYCHOEDUCATION; REM SLEEP; REVIEW; SLEEP DISORDER; SOMNOLENCE; SORE THROAT; TREATMENT PLANNING;

HUMANS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP WAKE DISORDERS;

EID: 84864832817     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2012.48.6.1729395     Document Type: Review

References (45)

1. Vgontzas, A.L. Insomnia with short sleep duration and mortality: The Penn State Cohort. Sleep 2010, 33(9): 1159-64.
2. Dijk, D., James, L. Sex differences and the effect of gaboxadol and zolpidem on EEG power specra in NREM and REM sleep. J Psychopharmacol 2010, 24(11): 1613-8.
3. Mitchell, H., Weinshenker, D. Good night and good luck: norepinephrine in sleep pharmacology. Biochem Pharmacol 2010, 79(6): 801-9.
4. Scammell, T., Winrow, C. Orexin receptor: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011, 51: 243-66.
5. Neylan, T., Mueller, S., Wang, Z. et al. Insomnia severity is associated with a decreased volume of the CA3/dentate gyrus hippocampal subfield. Biol Psychiatry 2010, 68(5): 494-6.
6. Bonnet, M., Arand, D. Hyperarousal and insomnia: state of the science. Sleep Med Rev 2010, 14(1): 9-15.
7. Bélangera, L., Morina, C., Langloisa, F., Ladouceur, R. Insomnia and generalized anxiety disorder: effects of cognitive behavior therapy for gad on insomnia symptoms. Anxiety Disord 2004, 18(4): 561-71.
8. Myers, E., Startup, H., Freeman, D. Cognitive behavioural treatment of insomnia in individuals with persistent persecutory delusions: a pilot trial. J Behav Ther Exp Psychiatry 2011, 42(3): 330-6.
9. Krakow, B., Ulibarri, V., Romero, E. Persistent insomnia in chronic hypnotic users presenting to a sleep medical center: a retrospective chart review of 137 consecutive patients. J Nerv Ment Dis 2010, 198(10): 734-41.
10. Wheaton, A., Perry, G., Chapman, D., McKnight-Eily, L., Presley-Cantrell L., Croft, J. Relationship between body mass index and perceived insufficient sleep among U.S. adults: an analysis of 2008 BRFSS data. BMC Public Health 2011, 11: 295.
11. Montgomery, P., Dennis, J. Physical exercise for sleep problems in adults aged 60+. Cochrane Database Syst Rev 2002, 4.
12. Bluestein, D., Healey, A., Rutledge, C. Acceptability of behavioral treatments for insomnia. J Am Board Family Med 2011, 24(3): 272-80.
13. Mendelson, W. Combining pharmacologic and nonpharmacologic therapies for insomnia. J Clin Psychiatry 2007, 68(Suppl. 5): 19-23. (Pubitemid 46847824)
14. Siriwardena, A., Apekey, T., Tilling, M., Dyas, J., Middleton, H., Ørner, R. General practitioners' preferences for managing insomnia and opportunities for reducing hypnotic prescribing. J Eval Clin Pract 2010, 16(4): 731-7.
15. Tiwari, A., Souza, R., Müller. D. Pharmacogenetics of anxiolytic drugs. J Neural Transm 2009, 116(6): 667-77.
16. Richardson, G., Roehrs, T., Rosenthal, L., Koshorek, G., Roth, T. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol 2002, 22(5): 511-5.
17. Tokunaga, S., Takeda, Y., Shinomiya, K., Hirase, M., Kamei, C. Effects of some H1-antagonists on the sleep-wake cycle in sleep-disturbed rats. J Pharmacol Sci 2007, 103(2): 201-6. (Pubitemid 46294652)
18. Nutt, D., Stahl, S. Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol 2010, 24(11): 1601-12.
19. Dündar, Y., Dodd, S., Strobl, J., Boland, A., Dickson, R., Walley, T. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 2004, 19(5): 305-22.
20. Pollack, M., Hoge, E., Worthington, J., Moshier, S., Wechsler, R., Brandes, M., Simon, N. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2011, 72(7): 892-7.
21. Owens, J. Pharmacotherapy of pediatric insomnia. J Am Acad Child Adolesc Psychiatry 2009, 48(2): 99-107.
22. Holshoe, J. Antidepressants and sleep: a review. Perspect Psychiatr Care 2009, 45(3): 191-7.
23. Wilson, S., Nutt, D., Alford, C., Argyropoulos, S. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010, 24(11): 1577-601.
24. Fetveit, A. Late-life insomnia: a review. Geriatr Gerontol Int 2009, 9(3): 220-34.
25. Krystal, A., Durrence, H., Scharf, M., Jochelson, P., Rogowski, R., Ludington, E., Roth, T. Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep 2010, 33(11): 1553-61.
26. Quera-Salva, M., Lemoine, P., Guilleminault, C. Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients. Hum Psychopharmacol 2010, 25(3): 222-9.
27. Hoque, R., Chesson A. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med 2010, 6(1): 79-83.
28. Gursky, J., Krahn, L. The effects of antidepresssants on sleep: a review. Harvard Rev Psychiatry 2000, 8(6): 298-306.
29. Winokur, A., Gary, K., Rodner, S., Rae-Red, C., Fernando, A., Szuba, M. Depression, sleep physiology, and antidepressant drugs. Depress Anxiety 2001, 14(1): 19-28. (Pubitemid 32801613)
30. DeMartinis, N., Winokur, A. Effects of psychiatric medications on sleep and sleep disorders. CNS Neurol Disord Drug Targets 2007, 6(1): 17-29. (Pubitemid 46322292)
31. Armour, A., Gottschlich, M., Khoury, J., Warden, G., Kagan, R. A randomized, controlled prospective trial of zolpidem and haloperidol for use as sleeping agents in pediatric burn patients. J Burn Care Res 2008, 29(1): 238-47.
32. van Liempt, S., Vermetten, E., Geuze, E., Westenberg, H. Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review. Int Clin Psychopharmacol 2006, 21(4): 193-202. (Pubitemid 43740296)
33. Plante, D., Winkelman, J. Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry 2008, 165(7): 830-43. (Pubitemid 351948715)
34. Wine, J., Sanda, C., Caballero, J. Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions. Ann Pharmacother 2009, 43(4): 707-13.
35. Coupland, N. Psychopharmacology for the clinician. J Psychiatry Neurosci 2009, 34: E5-E6.
36. Lo, H., Yang, C., Lo, H., Lee, C., Ting, H., Tzang, B. Treatment effects of gabapentin for primary insomnia. Clin Neuropharmacol 2010, 33(2): 84-90.
37. Srinivasan, V., Brzezinski, A., Pandi-Perumal, S., Spence, D., Cardinali, D., Brown, G. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(4): 913-23.
38. Wheatley, D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol 2005, 19(4): 414-21. (Pubitemid 41003139)
39. Vermeer, A., Coonan, A. Effects of the use of hypnotics on cognition. Prog Brain Res 2011, 190: 89-103.
40. Mets, M., de Vries, J., de Senerpont Domis, L., Volkerts, E., Olivier, B., Verster, J. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Sleep 2011, 34(10): 1327-34.
41. McClure, D., Walsh, J., Chang, H., Olah, A., Wilson, R., Pecknold, J. Comparison of lorazepam and flurazepam as hypnotic agents in chronic insomniacs. J Clin Pharmacol 1988, 28(1): 52-6.
42. Kales, A., Scharf, M., Soldatos, C., Bixler, E., Bianchi, S., Schweitzer, P. Quazepam, a new benzodiazepine hypnotic: intermediate-term sleep laboratory evaluation. J Clin Pharmacol 1980, 20(4, Pt. 1): 184-92.
43. McGechan, A., Wellington, K. Ramelteon. CNS Drugs 2005, 19(12): 1057-65. (Pubitemid 41775995)
44. Dooley, M., Plosker, G. Zaleplon: a review of its use in the treatment of insomnia. Drugs 2000, 60(2): 413-45.
45. Wheatley, D. Zopiclone: a non-benzodiazepine hypnotic controlled comparison to temazepam in insomnia. Br J Psychiatry 1985, 146: 312-4. (Pubitemid 15128907)